Crowdonomics
WatchlistPortfolio
This isn’t Shackelford Pharma Inc.’s most recent raise. Reg A+ · Equity · Jul 2022 (Closed) is more current.View latest round
Shackelford Pharma Inc.

Reg A+ · Equity · May 2020

ClosedReg A+Equity
via the platform · last checked Aug 16, 2026
Raised
$8.9M / $7.5M max
100% of ceiling
Investors
—
—
Estimated pre-money
$40M
—

Financials disclosed in this offering

FY2019 · hover for source
$0
FY2019
RevenueNet income
Metric
FY2019 audited
Income statement
Revenue
$0
Cost of goods sold
$0
Net income
$0
Balance sheet
Cash
$72,280
Accounts receivable
$29,876
Total assets
$90,508
Long-term debt
$0
Total liabilities
$119,424
Other
Headcount
1

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Amendments to this offering

4 amendments
  1. Aug 18, 2020
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  2. Aug 6, 2020
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  3. Jul 20, 2020
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗
  4. Jun 11, 2020
    Terms not yet extracted from this filing
    Form 1-A/A on EDGAR ↗

Each line compares the amendment with the previous filing of this offering. Form 1-A amendments state no reason; those filed before qualification are usually responses to SEC staff review.

Deal terms

Est. pre-money$40M
Price / share$1.00
Shares offered7,500,000

Estimated, not stated: $1.00 × 40,049,997 securities outstanding.

Offering details

Target—
Max$7,500,000
Min investment—
OpenedMay 4, 2020
Deadline—
ClosedJul 21, 2022
Days active808

Links & provenance

SEC filing
Source: SEC EDGAR
0001062993-20-002097
Last synced Aug 16, 2026

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.